![](../../files/images/goods/609-06-3.png)
L-Xylose
CAS No. 609-06-3
L-Xylose ( L-(-)-Xylose )
产品货号. M26735 CAS No. 609-06-3
L-木糖是木糖左旋异构体,属于戊醛糖型单糖。
纯度: >98% (HPLC)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
规格 | 价格/人民币 | 库存 | 数量 |
100MG | ¥235 | 有现货 |
![]() ![]() |
500MG | ¥518 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称L-Xylose
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述L-木糖是木糖左旋异构体,属于戊醛糖型单糖。
-
产品描述L-Xylose, a Xylose levo-isomer, is classified as the aldopentose type?monosaccharide.(In Vitro):The permeability characteristics of L-xylose have been compared in isolated intact rat diaphragm muscle preparations, in the absence and presence of exogenous insulin. In the absence of added insulin, L-xylose distributed in less than a third of the total cell water. In the presence of added insulin, intracellular distribution of L-xylose is increased. L-Xylose distributed in 50 per cent of the intracellular water. A significant lag period was observed before the insulin effect upon the penetration of L-xylose was evident. The lag period with L-xylose could be abolished by pretreating the tissues with insulin for 1 hour.
-
体外实验——
-
体内实验——
-
同义词L-(-)-Xylose
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number609-06-3
-
分子量150.13
-
分子式C5H10O5
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (666.09 mM)
-
SMILESOC[C@H](O)[C@@H](O)[C@H](O)C=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Thomaston JL, et al. Crystal structure of the drug-resistant S31N influenza M2 proton channel. Protein Sci. 2016 Aug;25(8):1551-4.
产品手册
![](/themes/theme/en/images/ct.png)
![](/themes/theme/en/images/new12.jpg)
![](/themes/theme/en/images/gift.jpg)
![](/themes/theme/en/images/ct2.png)
关联产品
-
5-(2-furyl)-N-propyl...
5-(2-呋喃基)-N-丙基异恶唑-3-甲酰胺是一种用作分子结构单元的化合物。
-
Blutene chloride
一种吩噻嗪,已用作止血剂、生物染色剂以及羊毛和丝绸的染料。
-
Sergliflozin etabona...
Sergliflozin etabonate 是一种 SGLT-2 抑制剂,可用于治疗 2 型糖尿病和肥胖症。